Recombinant human granulocyte macrophage colony stimulating factor (Kyowa Hakko Kirin)

重组人粒细胞刺激因子（协和发酵麒麟）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human granulocyte macrophage colony stimulating factor (Kyowa Hakko Kirin)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesKyowa Kirin Co LtdIse Plant, Nipro Pharma CorpWinHealth (China) Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Hakko Kirin Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A